Skip to Content


In the US, Colestipol (colestipol systemic) is a member of the drug class bile acid sequestrants and is used to treat Hyperlipoproteinemia, Hyperlipoproteinemia Type IIa - Elevated LDL and Hyperlipoproteinemia Type IIb - Elevated LDL VLDL.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Therapeutic Category

Lipid lowering agent: Bile acid sequestrant

Chemical Name

Copolymer of dietylenetriamine and 1-chloro-2,3-epoxypropane

Foreign Names

  • Colestipolum (Latin)
  • Colestipol (German)
  • Colestipol (French)
  • Colestipol (Spanish)

Generic Names

Brand Names

  • Colestid
    Farmea, Israel; Pfizer, Australia; Pfizer, Belgium; Pfizer, Canada; Pfizer, Switzerland; Pfizer, Spain; Pfizer, United Kingdom; Pfizer, New Zealand; Pharmacia & Upjohn, United States
  • Lestid
    Pfizer, Denmark; Pfizer, Norway; Pfizer, Sweden


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.